Malaria rapid diagnostic tests (RDT) have limitations due to the persistence of histidine-rich protein 2 (HRP2) antigen after treatment and low sensitivity of Plasmodium lactate dehydrogenase (pLDH) based RDTs. To improve the diagnosis of malaria in febrile children, two diagnostic algorithms, based on sequential interpretation of a malaria rapid diagnostic test detecting two different targets of Plasmodium species and followed by expert microscopy, were evaluated.
Two diagnostic algorithms were evaluated using 407 blood samples collected between April and October 2016 from febrile children and the diagnostic accuracy of both algorithms was determined. Algorithm 1: The result of line T1-HRP2 were read first; if negative, malaria infection was considered to be absent. If positive, confirmation was done with the line T2-pLDH. If T2-pLDH test was negative, the malaria diagnosis was considered as “inconclusive” and microscopy was performed; Algorithm 2: The result of line T2-pLDH were read first; if positive, malaria infection was considered to be present. If negative, confirmation was done with the line T1-HRP2. If T1-HRP2 was positive the malaria diagnosis was considered as “inconclusive” and microscopy was performed. In absence of malaria microscopy, a malaria infection was ruled out in children with an inconclusive diagnostic test result when previous antimalarial treatment was reported.
For single interpretation, the sensitivity of PfHRP2 was 98.4% and the specificity was 74.2%, and for the pLDH test the sensitivity was 89.3% and the specificity was 98.8%. Malaria was accurately diagnosed using both algorithms in 84.5% children. The algorithms with the two-line malaria RDT classified the test results into two groups: conclusive and inconclusive results. The diagnostic accuracy for conclusive results was 98.3% using diagnostic algorithm 1 and 98.6% using algorithm 2. The sensitivity and specificity for the conclusive results were 98.2% and 98.4% for algorithm 1, and 98.6% and 98.4% for algorithm 2, respectively. There were 63 (15.5%) children who had an “inconclusive” result for whom expert microscopy was needed. In children with inconclusive results (PfHRP2+/pLDH- only) previous antimalarial treatment was reported in 16 children with malaria negative microscopy (16/40; 40%) and 1 child with malaria positive microscopy (1/23; 4.3%).
Citation: Kiemde F, Bonko MdA, Tahita MC, Mens PF, Tinto H, Schallig HDFH, et al. (2019) Algorithms for sequential interpretation of a malaria rapid diagnostic test detecting two different targets of Plasmodium species to improve diagnostic accuracy in a rural setting (Nanoro, Burkina Faso). PLoS ONE 14(2): e0211801. https://doi.org/10.1371/journal.pone.0211801
Editor: Michelle L. Gatton, Quensland University of Technology, AUSTRALIA
Received: August 9, 2018; Accepted: January 21, 2019; Published: February 13, 2019
Copyright: © 2019 Kiemde et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: The work was financially supported by a grant from the Netherlands Organisation for Health Research and Development (ZonMw), project 205300005; RAPDIF: a rapid diagnostic test for undifferentiated fevers.
Competing interests: The authors have declared that no competing interests exist.
Nowadays, malaria parasite specific antigen-detecting rapid diagnostic tests (RDTs) are considered essential tools in routine practice for the management of febrile illness in malaria endemic settings   . The short time needed to obtain a diagnostic result (within 30 minutes), the simple read-out system and easy performance (no need for a conventional laboratory or extensive training), combined with relative low costs have contributed to the acceptance of this method in differentiating malaria fever from other causes of fever. The most commonly used RDTs in Africa, including Burkina Faso, are the Plasmodium falciparum histidine-rich protein 2 (PfHRP2) based RDT, which is specific for Plasmodium falciparum only, and the Plasmodium lactate dehydrogenase (pLDH) detecting RDT, which can detect 4 human Plasmodium species (Plasmodium falciparum, P. ovale, P. malariae and P. vivax) or a combination test, which has two test lines (a P. falciparum-specific line and an all human Plasmodium-test line).
In malaria endemic settings, several studies have been conducted to assess the sensitivity and specificity of PfHRP2 and pLDH-based RDTs using microscopy as the gold standard    . Most of these studies reported a relative low specificity for PfHRP2 detecting RDTs and low sensitivity for pLDH detecting tests (<95%). Consequently, PfHRP2 is useful for active detection of new malaria infection but unsuitable for monitoring parasite clearance following antimalarial treatment due to the persistence of HRP2 antigen in the blood for up to four weeks and over, which is causing false positive PfHRP2 results and information on prior drug use should always be collected       . On the other hand, pLDH is metabolized within one week following antimalarial treatment and RDTs based on detection of this particular antigen were found to be suitable for monitoring parasite clearance, but less useful to detect new infections with a relatively low parasitaemia . As a consequence, a malaria positive PfHRP2 based RDT may not signal also for another cause of fever and a malaria negative pLDH based RDT may not detect a low malaria parasitemia. So, the incidence of false positive PfHRP2 and false negative pLDH tests has created a diagnostic dilemma, often resulting in a loss of trust and non-adherence of health workers for malaria RDT results in general .
To circumvent this dilemma, sequential reading/interpretation of the two-line RDT detecting HRP2 and pLDH, specific of Plasmodium species, has been proposed.
The study was performed in the health district of Nanoro, central-west of Burkina Faso. Samples and data were collected in three peripheral health facilities (Nanoro, Nazoanga and Seguedin), and in the referral hospital, the Centre Médical avec Antenne Chirurgicale (CMA) Saint Camille of Nanoro. The only diagnostic tool available for the routine diagnosis of fever in patients seeking heath care in these clinics is a malaria RDT. The RDTs used in government clinics are one based on the detection of PfHRP2 (manufacturers: SD Bioline: Standard Diagnostics, Hagal-Dong, Korea; CareStart: Access Bio, Inc.). The management of uncomplicated medical cases, including uncomplicated malaria (positive malaria RDT), is done at the health facilities by nurses according to the national guideline of integrated management of childhood illness . Suspected malaria infection is the first reason for consultation in children under-5 years of age in this region and predominately occurs during the rainy season between July and November. The annual prevalence of malaria in children under-5 years of age has previously been determined to be 49.7% .
This study was conducted in the framework of a large program aiming to improve the diagnosis and management of non-malaria fevers in children under-5 years of age . Briefly, all febrile children (axillary temperature ≥37.5°C) under-5 years of age presenting in one of the three health facilities or the referral hospital between April and October 2016 were invited to participate in the study. Non-malaria infections which can be a probable cause of fever, such as bacterial bloodstream infection, gastroenteritis infection and urinary tract infection, were also investigated in the framework of this large survey . Written informed consent was obtained from parent/guardian before any data or clinical specimen was collected. Basic demographic data of the included children and information on prior treatment, including antimalarials, in the two weeks before enrolment where collected.
For the purpose of the study a venous blood sample was collected in an Ethylene Diamine Tetra Acetic acid (EDTA) tube from each participant and specimens were transported to the Central Laboratory of the Clinical Research Unit of Nanoro (CRUN) for diagnostic (re-)testing (expert malaria microscopy and RDT’s to detect PfHRP2 and pLDH). Malaria RDTs were ordered, stored and transported as recommended by the manufacturer (17–30°C). The patients were managed according to the national guideline and malaria RDT provided by the National Malaria Control Program (NMCP). The study was approved by the National Ethics Committee for Health Research of Burkina Faso (Deliberation N°2014-11-130).
Malaria rapid diagnostic test.
A volume of 5 μl of a blood sample collected in an EDTA tube was used to perform the malaria RDT. A two-line malaria RDT detecting both PfHRP2 and pLDH (SD Ag Bioline Malaria Ag P.f/Pan: Standard Diagnostics, Hagal-Dong, Korea; Lot number: 05EDC002A) with different lines specific for each target antigen and an internal control was used. The tests were performed and results recorded by a trained laboratory technician. A second trained technician also read and recorded the results of the RDT immediately after test execution and within the time limit set by the manufacturer. In case of discordance a third expert would be consulted to reach a decision. The test used in the present study went through the last WHO-FIND lot testing round 7 (Catalogue number: 05FK60) .
The performance of PfHRP2 and pLDH were interpreted separately for the purpose of the study. In addition, the performance of the two-line malaria RDT was also calculated according to the manufacturer’s instructions for the interpretation of the three lines malaria RDT (the test is positive if the at least one line of T1-HRP1 and T2-pLDH is positive and negative in case of absence of any positive line for the different targets).
To assess the performance of the proposed diagnostic algorithms including PfHRP2 and pLDH, the three lines of the employed malaria RDT were used. The test was valid if the internal control line was positive. The line T1-HRP2 is specific to Plasmodium falciparum and the line T2-pLDH is positive when P. falciparum, P. malariae, P. ovale or P. vivax is present. For the purpose of the study the results of the specific HRP2-line or the specific pLDH-line where separately recorded on a case report form (CRF). The following two diagnostic algorithms were considered within the recommended time of the manufacturer:
- Algorithm 1 and interpretation: Read line T1-HRP2 and confirmation with line T2-pLDH
For the interpretation for algorithm 1, the results of the line T1-HRP2 of blood samples tested form febrile children were read firstly: The absence of positive line T1-HRP2 indicates the absence of malaria infection and a confirmation with the line T2-pLDH is not required. However, the presence of a positive line for PfHRP2 indicates the necessity to confirm by reading the line T2-pLDH testing. The presence of positive line T2-pLDH (next to the positive line T1-HRP2) hence indicates the presence of malaria infection. The absence of a positive line T2-pLDH indicates that the diagnostic testing with RDTs was “inconclusive” and subsequently it was necessary to confirm the diagnosis with malaria expert microscopy (Fig 1).
- Algorithm 2 and interpretation: Read line T2-pLDH and confirmed with the line T1-PfHRP2
For the interpretation of algorithm 2, the results of the line T2-pLDH of blood samples tested from febrile children were read firstly: The presence of a positive line T2-pLDH indicates the presence of malaria infection and a confirmation with the line T1-HRP2 is not required. However, the absence of positive line T2-pLDH indicates the necessity to confirm with the line T1-HRP2. The absence of positive line T1-HRP2 (next to the absence of positive line T2-pLDH) indicates the absence of a malaria infection. The presence of positive line for T1-HRP2 indicates that the diagnostic testing with RDTs was “inconclusive” and that it was necessary to confirm the diagnosis with malaria microscopy (Fig 2).
If malaria microscopy to confirm the diagnosis in children with inconclusive diagnostic results is not available, additional information on previous antimalarial treatment within the past 2 weeks was used to exclude a malaria infection.
Malaria diagnosis by microscopy was done by expert microscopists at CRUN who are subjected to regular external quality control (National Institute of Communicable Diseases/World Health Organization; NICD/WHO). At CRUN only accredited microscopists are authorized to read malaria slides . Thick and thin blood smears were prepared (in duplicate) from blood collected in EDTA tubes as previously described. Thick blood smears were considered negative when the examination of 100 field per thick film did not reveal the presence of any asexual parasites. Each blood slide was read and parasite densities counted by two independent readers and in case of discrepancy (positive vs negative, difference in Plasmodium species, difference in parasite density >Log10 or ratio >2 in case of parasite density ≤400 or >400/μl, respectively) by a third reader . These results were expressed as asexual parasites per microliter by using the patient’s white blood cells (WBC) count. Positive microscopy results were recorded as the geometric means of the two reader’s results or the geometric means of the third reading and the closest reading of the two other readings. Microscopists were blinded from the malaria RDT results. A selection of slides (5%) was re-read by an independent expert microscopist for quality assurance.
Full blood counts.
Full blood cell counts were done by using blood samples collected in EDTA tubes and a Sysmex XS1000i (Sysmex Corporation, Kobe, Japan) according to manufacturer’s instructions.
Diagnosis of non-malaria infections.
The methods applied for the diagnosis of non-malaria infections were in detail described previously . Blood and urine specimen were systematically collected for bacterial culture, and stools for rotavirus and adenovirus tests.
Data was entered in Excel 2016. Statistical analysis was performed by using R software version 3.3.1 (R Foundation for Statistical Computing, Vienna, Austria). For the purpose of this study, malaria microscopy was considered as gold standard. Sensitivity, specificity and predictive values were calculated for PfHRP2, pPDH, the two-line malaria RDT (Pf/Pan) as recommended by the manufacturer and the two algorithms proposed. Proportion was used to describe qualitative data. For the quantitative data median was used to perform the description. Wilcoxon Rank Sum test was used to compare the median by estimating the p-value (p≤0.005) as statistically significant. Agreement between diagnostic approaches was determined by calculating Kappa (κ) values with 95% confidence intervals by using GraphPad software (https://www.graphpad.com/quickcalcs/).
Characteristics of the study population
A total of 407 children under 5 years of age with documented fever were included in the study (Table 1). Of these children, 56.8% (231/407) were males and 25.6% (104/407) was under the age of 12 months. Plasmodium falciparum was found by expert microscopy in 60.0% (244/407) of the blood slides, and 5 falciparum patients were co-infected with other malaria species (four with P. malariae and one with P. ovalae). The median parasite density was 39,847 (Interquartile range [IQR]: 7,828–95,369).
Performance of two-line malaria RDT detecting PfHRP2/pLDH (P.f/Pan) compared to expert microscopy.
Expert microscopy was, for the purpose of this study, considered as the gold standard. Based on the manufacturer’s instructions, the P.f/Pan-based RDT was able to accurately diagnose 362 cases: i.e. 241 true positive cases (59.2%) and 121 true negative cases (29.7%). However, the P.f/Pan-based RDT had 42 (10.3%) false positive results and 3 (0.7%) false negative results (Table 2). The performance of PfHRP2 and pLDH are also reported on Table 2.
The diagnostic accuracy of the P.f/Pan-based RDT results compared to expert microscopy as gold standard are presented in table 3. The sensitivity, specificity, positive predictive value and negative predictive value were 98.8% (241/244), 74.2% (121/163), 85.2% (241/283) and 97.6% (121/125) respectively. The agreement between PfHRP2 testing and expert microscopy was considered to be “good; kappa value = 0.760 (95% CI 0.696 to 0.825; SE of kappa = 0.033). The sensitivity, specificity, positive predictive value and negative predictive value were respectively 98.4%, 74.2%, 85.1% and 96.8% for PfHRP2 target and 89.3%, 98.8%, 99.1% and 86.1% for pLDH target (Table 3).
Diagnostic performance of algorithm 1 and 2
The diagnostic performance of algorithm 1 and 2 was comparable (Table 4). Algorithm 1 (read firstly the line T1-HRP2, followed by confirmation with the line T2-pLDH) resulted in 344 RDT confirmed diagnostic results: 219 positive cases and 125 negative cases. There were 63 “inconclusive” results (15.5% of all cases) that would require a final confirmation with microscopy if this algorithm would be applied. Algorithm 2 (read firstly the line T2-pLDH, confirmation with the line T1-HRP2) resulted also in 63 “inconclusive” results, and 220 positive and 124 negative cases. The algorithm 1 and 2 classified the diagnostic results in two groups: the conclusive diagnostic results in 84.5% (344/407) of children tested for which any additional information is not required to confirm malaria infection and the inconclusive diagnostic results in 15.5% (63/407) of children tested for which additional investigation is required following the algorithms. The conclusive results had higher median of parasites density of 45746 parasites/μl (IQR: 16618–101972) compared with inconclusive results with median of parasite density 778 parasites/μl (IQR: 119–1059.75) (p<0.0001).
There were thus 63 “inconclusive” test results with either employed diagnostic algorithm. For a final diagnostic result, these cases (15.5% of the whole study population) should be retested with expert microscopy. In the case of algorithm 1 and 2, these “inconclusive” test results comprised 23 cases that were found positive with expert microscopy and 40 cases that were reported as negative. Previous antimalarial treatments were collected within 2 weeks preceding inclusion. Despite the limit (HRP2 antigens can persist over 4 weeks), in children with inconclusive test (PfHRP2+/pLDH- only), previous antimalarial treatments were reported in 16 children with malaria negative microscopy (16/40; 40%) and 1 child with malaria positive microscopy (1/23; 4.3%). Moreover, non-malaria infections (bacterial bloodstream infection, viral gastroenteritis infection and urinary tract infection) were diagnosed in 10 children with malaria negative microscopy (10/40; 25%) and 2 children with malaria positive microscopy (2/12; 8.7%; parasite density of 32 and 78 parasites/μl).
The agreement between expert microscopy and the two diagnostic algorithms on the 344 conclusive test results (i.e. those that were not requiring confirmation with microscopy) is summarized in Table 5. The frequency of true positives was similar in algorithm 1 and 2 (63.1% and 63.4% respectively) as well as the frequency of true negatives (35.2% for the both). Furthermore, the frequency of malaria false positives was similar in algorithm 1 and 2 (0.6%) as well as the frequency of false negatives (1.2% versus 0.9% respectively). The agreement between expert microscopy and diagnostic algorithm 1 (using the results of the “conclusive” RDT test results only) was “very good” (Kappa = 0.962; 95% CI 0.932 to 0.992; SE of kappa = 0.015). Furthermore, the agreement between diagnostic algorithm 2 and expert microscopy was in this case also “very good” (Kappa = 0.968; 95%CI 0.941 to 0.996; SE of kappa = 0.014).
Algorithm 1 is: first reading HRP2-line and subsequent confirmation with a pLDH-line; Algorithm 2 is: reading with a pLDH-line and confirmation with a HRP2-line.
For the 344 “conclusive” diagnostic RDT results, the sensitivities, specificities, positive predictive values and negative predictive values were similar for algorithm 1 and 2 (Table 6). These values were 98.2% (217/221), 98.4% (121/123), 99.1% (217/219) and 96.8% (121/125) for algorithm 1, and for algorithm 2, 98.6% (218/221), 98.4% (121/123), 99.1% (218/220) and 97.6% (121/124).
When prior antimalarial treatment within the past 2 weeks was used to exclude malaria infection in children with inconclusive diagnostic result (hence considering them as being negative), the sensitivities, specificities, positive predictive values and negative predictive values calculated, were similar for algorithm 1 and 2. These values were 98.0%, 84.0%, 90.2% and 96.5% for algorithm 1 and 98.4%, 84.0%, 90.2% and 97.2% for algorithm 2, respectively.
Consequently, inadequate prescription of antimalarial observed with PfHRP2-based RDT could be improved (26 cases when algorithms are used compared to 42 children when PfHRP2-based RDT only is used). Moreover, malaria infection could be missed in 5 children when algorithms are used versus 4 children when PfHRP2-based RDT is used [data not show].
The results of two diagnostic algorithms under evaluation demonstrated that the true and false results, which could not be diagnosed with single malaria RDT, could now be diagnosed and the test result can be classified in two groups: (i) the conclusive results for which malaria was diagnosed with a higher accuracy (>98%) following the algorithms; (ii) the inconclusive results for which malaria microscopy or additional investigation is required to better diagnose malaria in this group. The high sensitivity and specificity (>98%) of the algorithms for conclusive results only proofs that potential false positive and negative results could be identified by healthcare workers in a primary healthcare setting to improve the diagnosis of an ongoing infection. Consequently, healthcare workers are better able to accurately diagnose malaria in this group. This study also reported an association between the inconclusive results and the low malaria parasitemia, which is in line with other studies that reported that the low sensitivity of pLDH and the high sensitivity of PfHRP2 leads to malaria false negative and positive results respectively. Moreover, after successful antimalarial treatments, pLDH antigen is metabolised within one week, but HRP2 antigens can persist in the blood up to 4 weeks and over. It is evident that low malaria parasitemia and persistence of HRP2 antigen after successful antimalarial treatment could lead to inconclusive diagnostic results (HRP2+/pLDH-) following the algorithms. A previous study reported that in a malaria endemic area, almost 50% of non-malaria infection due to bacteria and virus can be hide under a false positive HRP2 results . Based on this observation, it is obvious that inconclusive diagnostic result reported in the present study is due either to low parasitemia or non-malaria infection occurred after a successful antimalarial treatment.
The association between false positive HRP2 results and previous antimalarial treatment within the past 4 weeks (or more) has been reported by Maltha et al. and Dalrymple et al.  . It is therefore obvious that in absence of malaria microscopy, additional information on previous antimalarial treatment could be used to further establish the actual cause of fever in children with inconclusive test results. In the present study, information on previous antimalarial treatment partly resolved inconclusive diagnostic results, this is however a limited solution in the present study as only information on previous use in the last 2 weeks (and not 4 weeks) was collected. In routine practice, healthcare workers should firmly ask for information on previous malaria treatment within the past 4 weeks to further establish the actual cause of fever in children with inconclusive test results.
Despite the limit in the collection of information on previous antimalarial treatments to resolve the inconclusive results, the diagnostic accuracies for the algorithms were higher than either test band individually reported in the present study and those reported by Hawkes et al. (sensitivity = 88%; specificity = 82%) . Consequently, the sequential interpretation of a two-line malaria RDT detecting both PfHRP2 and pLDH could improve the diagnostic accuracy of malaria infection if the sequential interpretation proposed is supported by information on previous antimalarial treatment within the last 4 weeks in children with inconclusive results. In other words, the limitations of separately interpreting PfHRP2 RDT, pLDH RDT or two-line malaria RDT detecting PfHRP2 and pLDH can be greatly avoided. The sequential interpretation of the two-line malaria RDT detecting PfHRP2/pLDH, supported by information on previous antimalarial treatment could improve the diagnostic accuracy. This approach can improve the management of febrile cases. The algorithms evaluated provided reliable alternatives to circumvent the diagnostic dilemma created by the use of a single malaria RDT. Malaria was accurately diagnosed with a diagnostic accuracy of 98.3% using diagnostic algorithm 1 or 98.6% with diagnostic algorithm 2. There were cases of febrile children (15.5%) in this study who had an “inconclusive” diagnostic test result and for whom expert malaria microscopy or other additional diagnostic and clinical investigations would be needed in order to do not miss potential treatable etiologies, including malaria. This indicates that both algorithm 1 and 2 can be helpful to accurately diagnose malaria in the majority of febrile children (84.5%). Both approaches eliminate doubts on the reliability of the diagnostic results achieved with the RDTs and the subsequent risk of having a malaria false positive or negative test result. The algorithms are designed for the diagnosis of Plasmodium falciparum only in area where PfHRP2-based RDT are currently used. It is evident that the presence of non-falciparum species, such as Plasmodium vivax, could impact the interpretation of the algorithms.
The number of malaria diagnostics results that were considered “conclusive” in our study with either algorithm was higher (84.5%) than that reported by Murungi et al (65.9%)  who followed a similar approach. Although the more sensitive polymerase chain reaction testing was not performed in our study, the sensitivity and specificity of the malaria diagnostic testing reported by Murungi for children under– 5 years was almost similar to that reported in our study on conclusive diagnostic test results; i.e. 100% for Murungi versus 98% in our study. In our study, 4 malaria microscopy positive cases (2 Plasmodium falciparum, 2 other Plasmodium species) were missed by our approach. Furthermore, there were two cases reported positive by our RDT approach, but with expert microscopy no parasites were found in the blood slides.
A group of children (n = 63; 15.5%) remained undiagnosed as testing for malaria with the proposed algorithms did not result in a conclusive malaria diagnosis. These children were ill as they had fever and 23 of them had malaria infection confirmed by microscopy, prompting the need of additional testing if the RDT approach proposed in this study remains inconclusive. These cases were PfHRP2+/pLDH- possibly due to previous anti-malarial treatment resulting in persisting HRP2 antigen  or the low sensitivity of pLDH which is likely not to detect often parasite level below 2,000 parasites/μl . In absence of malaria microscopy, healthcare workers should pay more attention to these children because these inconclusive tests could conceal either a true malaria infection or non-malaria infections. In primary healthcare settings, nurses are responsible for health care and trained to manage uncomplicated infections based on clinical signs and symptoms, except malaria. So, it is evident that the information on the previous antimalarial treatment and non-malaria infections collected (based on signs and symptoms) could be helpful for clinical decision. Finally, clinicians should always pay particular attention to those children who are confirmed negative for malaria but do show clinical signs (like fever) as they may have other treatable causes of fever, such as bacterial infections .
This study was conducted in a seasonal malaria transmission setting and most samples were collected during the rainy season (July-October) when malaria transmission is high. Fewer children were included during the dry season (April-June). The intensity of malaria transmission could therefore influence the choice of which diagnostic algorithm is employed, but this has not been studied. Another potential limitation of algorithm 1 and 2 is in settings were HRP2 deletions occur   . In such a setting a HRP2-line will always be negative, even if an infection with P. falciparum is present. Consequently, in malaria endemic regions where HRP2 deletions are well established, the implementation of the proposed algorithms could increase the number of inconclusive results and misdiagnose some cases of malaria infection.
Finally, most likely the implementation of the proposed algorithms would be by sequentially using two different RDTs. However, this approach can double the time needed to confirm the diagnosis of a malaria infection as the result of the second test needs to be available too, and thismay also require taking a second blood sample. Research is needed towards patient and health care provider acceptability of such an approach.
The strategy of sequential interpretation of two-line malaria RDT can improve the diagnosis of malaria by grouping the low malaria parasitemia and false HRP2 positive children in inconclusive test for which additional investigations on previous antimalarial treatments are required.
We would like to thank the study staff of the rural health facilities and the hospital CMA Saint Camille de Nanoro for their valuable contributions to the work. We are indebted to the children and their parents or legal guardians for their participation in the study.
- 1. WHO. Guidelines for the treatment of malaria, 2nd edition. Geneva, World Heal Organ. 2010;197.
- 2. Thiam S, Thior M, Faye B, Ndiop M, Diouf ML, Diouf MB, et al. Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests. PLoS One. 2011;6(4).
- 3. Kyabayinze DJ, Asiimwe C, Nakanjako D, Nabakooza J, Counihan H, Tibenderana JK. Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. Malar J. 2010;9:200. pmid:20624312
- 4. Maltha J, Guiraud I, Lompo P, Kabore B, Gillet P, Van Geet C, et al. Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso. Malar J. 2014;13:20. pmid:24418119
- 5. Hendriksen ICE, Mtove G, Pedro AJ, Gomes E, Silamut K, Lee SJ, et al. Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of african children. Clin Infect Dis. 2011;52:1100–7. pmid:21467015
- 6. Barber BE, William T, Grigg MJ, Piera K, Yeo TW, Anstey NM. Evaluation of the Sensitivity of a pLDH-Based and an Aldolase-Based Rapid Diagnostic Test for Diagnosis of Uncomplicated and Severe Malaria Caused by PCR-Confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivax. J Clin Microbiol. 2013;51:1118–23. pmid:23345297
- 7. Ochola LB, Vounatsou P, Smith T, Mabaso ML, Newton CR. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence of a gold standard. Lancet Infect Dis. 2006;6:582–8. pmid:16931409
- 8. Abba K, Deeks JJ, Olliaro P, Naing C, Jackson SM, Takwoingi Y, et al. Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev. 2011;CD008122. pmid:21735422
- 9. Wilson ML. Malaria rapid diagnostic tests. Clin Infect Dis. 2012;54:1637–41. pmid:22550113
- 10. Dalrymple U, Arambepola R, Gething PW, Cameron E. How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malar J. 2018;17(1).
- 11. Maltha J, Guiraud I, Lompo P, Kaboré B, Gillet P, Van Geet C, et al. Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina Faso. Malar J. 2014;13(1).
- 12. Hawkes M, Conroy AL, Opoka RO, Namasopo S, Liles W, John CC, et al. Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J. 2014;13(1):43.
- 13. Bisoffi Z, Sirima BS, Angheben A, Lodesani C, Gobbi F, Tinto H, et al. Rapid malaria diagnostic tests vs. clinical management of malaria in rural Burkina Faso: safety and effect on clinical decisions. A randomized trial. Trop Med Int Heal. 2009;14:491–8.
- 14. World Health Organization. Integrated Management of Childhood Illness (IMCI). World Heal Organ. 2010;
- 15. Kiemde F, Bonko M dit A, Tahita MC, Lompo P, Rouamba T, Tinto H, et al. Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission. Malar J. 2017;16:294. pmid:28728558
- 16. World HealthOrganization. Malaria rapid diagnostics test performance: results of WHO product testing of malaria RDTs: round 7 (2015–2016). World Heal Organ. 2017;7.
- 17. Tinto H, Valea I, Sorgho H, Tahita MC, Traore M, Bihoun B, et al. The impact of clinical research activities on communities in rural Africa: The development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso. Malar J. 2014;13(1).
- 18. Murungi M, Fulton T, Reyes R, Matte M, Ntaro M, Mulogo E, Nyehangane D, Juliano JJ, Siedner MJ, Boum Y 2nd B R. Improving the specificity of P. falciparum malaria diagnosis in high transmission settings with a two-step RDT and microscopy algorithm. J Clin Microbiol. 2017;
- 19. Gatton ML, Rees-Channer RR, Glenn J, Barnwell JW, Cheng Q, Chiodini PL, et al. Pan-Plasmodium band sensitivity for Plasmodium falciparum detection in combination malaria rapid diagnostic tests and implications for clinical management. Malar J. 2015;14(1):115.
- 20. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, et al. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg. 2012;86:194–8. pmid:22302847
- 21. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J. 2013;12:34. pmid:23347727
- 22. Deme AB, Park DJ, Bei AK, Sarr O, Badiane A, Gueye PEH, et al. Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests. Malar J. 2014;13:34. pmid:24472178